HEPATITIS-B-VIRUS-OBERFLÄCHENANTIGENHEMMER

Patent europeic · EP3632914 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3632914
Numer da la dumonda
EP18805272
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
22-05-2018
Publitgà
08-04-2020
Concedì
31-08-2022
Stritgà
23-12-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 471/04 (2006.01)
A61K 31/55 (2006.01)
A61P 31/20 (2006.01)
Prioritad
CN 201710365328 22.05.2017
Dumonda PCT
PCT/CN2018/087852 22.05.2018
Publicaziun PCT
WO2018/214875 29.11.2018
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-12-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.12.2023

  2. 12-07-2023

    Midada

    Published in Swissreg on 12.07.2023

  3. 31-08-2022

    Concedì

    Published in Swissreg on 31.08.2022

Partidas

Possessur

Fujian Akeylink Biotechnology Co., Ltd.

Building 1-7, Fuyuan Industrial Zone Zherong County, Ningde, Fujian 355300, CN

Inventur

HU, Yanbin

Shanghai 200131, CN

CHEN, Shuhui

Shanghai 200131, CN

SUN, Fei

Shanghai 200131, CN

DING, Charles Z.

Shanghai 200131, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.